All posts by: Michael Zand

About Michael Zand

Keeping moving—flat worms shed light on role of migrating stem cells in cancer – Phys.Org

Continue reading

2017-10-03 NEWS

Phys.Org

Keeping moving—flat worms shed light on role of migrating stem cells in cancer
Phys.Org
‘We already knew that these worm stem cells have a lot in common with our own stem cells, but we knew nothing about how they migrate and if this process relates to how our cells migrate,’ says Dr Prasad Abnave, first author of the study, published in …

and more »

Continue reading

2017-10-03 NEWS

New gene therapy to treat cancer in children, young adults offers hopes and challenges
News-Medical.net
The first gene therapy for cancer, approved by the Food Drug Administration in August, will transform the treatment of a particular kind of cancer in children and young adults. It’s transformative because it uses a patient’s own immune cells to attack
The FDA on gene therapyThe Pharma Letter

all 2 news articles »

Continue reading

2017-10-03 NEWS

University of California

DNA mutations found in blood predict response to immunotherapy in patients with cancer
University of California
In a first-of-its-kind study, University of California, San Diego School of Medicine researchers report that a blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies. “We can help predict
DNA mutations shed in blood predicts response to immunotherapy in patients with cancerMedical Xpress
DNA mutations in blood predict response to immunotherapyUPI.com
Study Demonstrates Potential for the Guardant360 Assay® to Predict Which Patients Will Benefit from ImmunotherapyMarkets Insider
Doctors Lounge
all 7 news articles »
Continue reading

2017-10-02 NEWS

Seeker

Continue reading

2017-10-02 NEWS

FierceBiotech

News of Note—Gene therapy to restore sight; umbilical cord cells to repair hearts; studying a Parkinson’s drug in
FierceBiotech
Researchers at Oxford University used gene therapy to reverse retinitis pigmentosa in mouse models of the disease, which is a common cause of blindness in young people. They delivered a gene that makes the light-sensing protein melanopsin to the …